SIGNALLING PATHWAYS AND MOLECULAR TARGETS FOR SKIN CANCER: INVOLVEMENT OF CDK2 INHIBITION. NUJPS [Internet]. 2018 Jun. 30 [cited 2025 Apr. 3];5(1):41-58. Available from: https://journals.nirmauni.ac.in/index.php/pharmacy/article/view/455